Tag: Pfizer
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer logo The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: AP) Frankfurt The US group Pfizer is using its billions in revenue from…
US stock exchanges start stable – bank shares lose significantly in value
Traders on the New York Stock Exchange US bank stocks plummet. (Photo: IMAGO/Xinhua) Frankfurt The fear of a banking crisis continues to keep the global capital markets in its grip.…
Cinven is examining the complete takeover of a laboratory chain – the share is on the up
Synlab lab The company has already launched a savings program that will save around 25 million euros in 2022. (Photo: Reuters) Frankfurt Almost two years after the IPO, Synlab’s major…
Pfizer acquires cancer specialist Seagen for $43 billion
Pfizer The US pharmaceutical company takes over the cancer specialist Seagen for 43 billion dollars. (Photo: Bloomberg via Getty Images) Frankfurt The US pharmaceutical company Pfizer is planning one of…
Ark Invest update: Cathie Wood hardly buys
Cathie Wood The well-known tech investor only bought new shares worth almost 90 million dollars in February. (Photo: Reuters) Dusseldorf Rising interest rate expectations have slowed the rally in tech…
Ark Invest update: Cathie Wood hardly chews
Cathie Wood The well-known tech investor only bought new shares worth almost 90 million dollars in February. (Photo: Reuters) Dusseldorf Rising interest rate expectations have slowed the rally in tech…
Bayer benefits from the agricultural business – but expects profits to fall in 2023
Dusseldorf The chemical and pharmaceutical group Bayer achieved record results in 2022, but will not be able to maintain this in the current year. For 2023, Bayer forecasts a decline…
Bayer benefits from the agricultural business – but expects profits to fall in 2023
Dusseldorf The chemical and pharmaceutical group Bayer achieved record results in 2022, but will not be able to maintain this in the current year. For 2023, Bayer forecasts a decline…
Bayer benefits from the agricultural business – but expects profits to fall in 2023
Dusseldorf The chemical and pharmaceutical group Bayer achieved record results in 2022, but will not be able to maintain this in the current year. For 2023, Bayer forecasts a decline…
Bayer benefits from the agricultural business – but expects profits to fall in 2023
Dusseldorf After two years of significant growth, the prospects for the pharmaceutical and agricultural group Bayer are clouding over. For 2023, the Leverkusen-based company only expects a slight increase in…
Pfizer is probably exploring the Seagen takeover – the pharmaceutical industry is facing a wave of takeovers
In the Pfizer lab Important patents are expiring at the US pharmaceutical company. (Photo: Bloomberg) Frankfurt Another major takeover may be in the offing in the pharmaceutical industry. According to…
With German research to number two in the pharmaceutical industry
Frankfurt The German pharmaceutical industry has a long tradition in immunology – and is still very efficient when it comes to researching new medicines. Commercially, two US companies are currently…
Seven funds with which they invest in the healthcare industry
Innovation in the healthcare industry Innovations in the sector always offer investment opportunities. (Photo: IMAGO/Westend61) Cologne From an investor perspective, the healthcare sector offers solid growth prospects. The world population…
This Altcoin Rises After Pfizer News
Focusing on longevity studies, VitaDAO received $4.1 million in funding from a group of investors, including Pfizer Ventures. Decentralized autonomous organizations (DAO) VitaDAO received investments from pharmaceutical giant Pfizer’s investment…
How the Greens want to polish their image in business
Berlin A group of medium-sized entrepreneurs wants to create a platform to expand the dialogue with the Greens and to make faster progress on the way to climate neutrality by…
Market insight: Europe’s stocks stand out
Europe stock markets Since the beginning of the year, European stocks have performed significantly better than the American stock market. There are several reasons for this. Dusseldorf The almost familiar…
Moderna scores with vaccine against RS virus
Frankfurt The US biotech group Moderna has underpinned the performance of its mRNA technology with another positive study. Its vaccine candidate “mRNA-1345” against the respiratory syncytial virus (RSV) achieved a…
China data and bank figures hit US markets – Wall Street closes in the red
new York Disappointing quarterly results from major US banks and economic data from China dampened Wall Street investors’ spirits on Tuesday. The Dow Jones index of standard values closed 1.1…
New Disclosure from Elon Musk: Pfizer Silenced Vaccine Opponents
A new one has been added to Elon Musk’s Twitter disclosures. Once again, the COVID-19 revelation highlights how Pfizer is putting pressure on the platform to monetize children. After buying…
Wall Street gives back some gains under Fed minutes
new York US investor optimism has eased somewhat following the release of minutes from the US Federal Reserve’s December meeting on Wednesday. Market barometers limited their gains in late US…